C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21

AIMS/HYPOTHESIS: Diabetic nephropathy is the leading cause of end-stage renal disease. Previously we reported that C66, a novel analogue of curcumin with a very high bioavailability, ameliorated diabetic nephropathy in mice, with little known about the mechanism. The present study aimed to define th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetologia
Egile Nagusiak: Wu, Hao, Kong, Lili, Tan, Yi, Epstein, Paul N., Zeng, Jun, Gu, Junlian, Liang, Guang, Kong, Maiying, Chen, Xiangmei, Miao, Lining, Cai, Lu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5260795/
https://ncbi.nlm.nih.gov/pubmed/27115417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-016-3958-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak